WHO suspends Indian vax purchases as it probes quality

Email LinkedIn
Tools

Perplexed by the appearance of mysterious white sediment inside vials of vaccine produced by an Indian subsidiary of Sanofi-Aventis, the World Health Organization has suspended the purchase and distribution of its Shan5 jab. According to Sanofi, the move comes as a "precautionary measure pending outcome of an investigation of vaccine quality."

A spokesperson for the WHO insists that there have been no safety problems yet discovered with the vaccine, a shot that provides protection against diphtheria, pertussis, tetanus, Haemophilus influenza B, and hepatitis B. However, even after vigorous shaking, the sediment was hard to disperse. And that, she adds, is a rare problem.

India's Shantha Biotechnics landed a contract valued at $340 million last fall to supply the vaccine to the WHO through 2012--just months after Sanofi bought it.

- here's the Wall Street Journal report

Related Articles:
Sanofi to donate 100M doses of new flu vaccine
Mass vaccination program could target schools